February 6, 2025
RegMed Investors (RMi) Closing Bell: breaking a rack in pool, what’s different?
February 5, 2025
RegMed Investors (RMi) Closing Bell: back on the horse going forward
February 4, 2025
RegMed Investors (RMi) Closing Bell: follow the bouncing share pricing
February 3, 2025
RegMed Investors (RMi) Closing Bell: a roller coaster
February 1, 2025
RegMed Investors (RMi) Closing Bell: another reverse in a volatile week for the cell and gene therapy sector
January 30, 2025
RegMed Investors (RMi) Closing Bell: share pricing leaps and a few bounds
January 29, 2025
RegMed Investors (RMi) Closing Bell: a little more of the same
January 28, 2025
RegMed Investors (RMi) Closing Bell: adding to investor agita
January 27, 2025
RegMed Investors (RMi) Closing Bell: a strange turn of events
January 24, 2025
RegMed Investors (RMi) Closing Bell: investor ambiguity points to downdraft of share pricing
January 23, 2025
RegMed Investors (RMi) Closing Bell: How investors can best navigate the sector ahead
January 22, 2025
RegMed Investors (RMi) Closing Bell: Getting little too frothy
January 21, 2025
RegMed Investors (RMi) Closing Bell: a share pricing dose of relief
January 17, 2025
RegMed Investors (RMi) Closing Bell: the green on the screen as week closes, thankfully
January 16, 2025
RegMed Investors (RMi) Closing Bell: a sector stampede to the downside
January 15, 2025
RegMed Investors (RMi) Closing Bell: a sigh of relief
January 14, 2025
RegMed Investors (RMi) Closing Bell: back in the bag
January 13, 2025
RegMed Investors (RMi) Closing Bell: JPMorgan Healthcare conference kicks-off
January 10, 2025
RegMed Investors (RMi) Closing Bell: diminished expectations ignite weekly declines
January 8, 2025
RegMed Investors (RMi) Closing Bell: a sector downward shuffle
January 7, 2025
RegMed Investors (RMi) Closing Bell: share pricing sustainability wavers
January 6, 2025
RegMed Investors (RMi) Closing Bell: bubblicious?
January 3, 2025
RegMed Investors (RMi) Closing Bell: 2nd session 2025
January 2, 2025
RegMed Investors (RMi) Closing Bell: first session 2025, cell and gene therapy sector bounced as indexes slumped
December 31, 2024
RegMed Investors (RMi) Closing Bell: lordy, lordy, thanks from above, we’ve had enough
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors